LCX. President / Director of Cardiology / New Tokyo Hospital
|
|
- Cecily Golden
- 5 years ago
- Views:
Transcription
1 LCX President / Director of Cardiology / New Tokyo Hospital Professor of Department of Advanced Cardiovascular Medicine: Kumamoto University Consultant / National Cardiovascular Center / Osaka Sunao Nakamura FACC, FAHA, FESC, FSCAI
2 72yo F. LMT-CTO, Very Low EF(EF20%) Dx: Course: Coronary Risk F: Renal F: LV Function: Euroscore: UAP/ Chronic Heart Failure 2003 (67 yo) Admission doe to AHF on CHF CAG (LMT CTO EF:19%) Admission due to re-acute HF 2004 (68 yo) re-cag consult Cardiac Surgeon Refuse, refer to Dr. Nakamura HL,Obesity, Current Smoker, FH Cr: 1.12 EF: 20 % %
3 72yo F. LMT-CTO, Very Low EF(EF20%) LVG (EF: 19%) LMT CTO
4 72yo F. LMT-CTO, Very Low EF(EF20%) Collateral angiogram Post PCI
5 72yo F. LMT-CTO, Very Low EF(EF20%) 1 year later No Restenosis, LVEF 19 40%
6 10 Years Later... (after open LMT Chronic Total Occlusion)... -At the same hospital, I met her again, because she wanted to meet me...?? :act of grace by Taiwan Dr.- She survived...
7 Pre
8 Pre Post
9 Pre Post F/U
10 Pre Post F/U EF: 66% No change: pre and post Patients: No Symptom
11 Japanese multicenter registry of CTO PCI 6 Institutions New Tokyo Hospital Department of Cardiology Kumamoto University Department of Cardiovascular Medicine Yamanashi University Department of Cardiovascular Medicine Fukuyama Cardiovascular Hospital Department of Cardiovascular Medicine Suzumoto Genaral Hospital Department of Cardiovascular Medicine Tenyoukai Central Hospital Department of Cardiovascular Medicine Success rate 92.5% Successful CTO PCI 1317 lesions PCI for CTO Jan Dec patients 1424 lesions Unsuccessful CTO PCI 184 lesions Without Clinical follow-up 77 patients/ 80 lesions
12 Long-Term Outcome of Percutaneous Coronary Intervention For Chronic Total Occlusions with DES in New Tokyo Hospital Unpublished Data : Satoru Mitomo, Sunao Nakamura, et al Interestingly, Impact of after procedural revascularization success of cardiac CTO at mortality LAD and RCA fatal prognosis in CTO was PCI improved, according however to CTO it vessels was not changed in the case of CTO at LCX. Cumulative incidents of Cardiac death P=0.005 LAD RCA LCx success unsuccess 20.7% vs. 12.5% Log Rank p=0.005 P<0.001 success unsuccess 25.6% vs. 5.8% Log Rank p<0.001 success unsuccess 0.0% vs. 4.2% Log Rank p=0.55 Follow-up days Follow-up days Follow-up days
13 Hypothesis?? Degree of improvement of fatal prognosis brought by CTO revascularization may differ depending on which artery among coronary arteries is re-vascularized. LCX??
14 The MIlan and New-TOkyo (MITO) Registry Among LMT PCI, some specific cases are still challenged with restenosis and MACE. Seeking for solution of these unsolved challenges, we decided to conduct data review of our own cases. Under the guidance of Dr. Antonio Colombo and Dr. Alaide Chieffo, our staff compiled data of our hospital and that of Milan as MITO Registry. Me Toru DR.Colombo DR. Chieffo
15 MIlan and New-TOkyo (MITO) Registry Between April 2002 and Jun 2015 New-Tokyo n=990 Milan n=520 From 2005 April 2002 April MITO Registry Total 1510 patients 1 st DES N=765 2 nd DES N=745
16 About Long-term Survival After LMT PCI
17 The impact of Main Branch Restenosis on Long Term Mortality Following Drug-eluting Stent Implantation in Patients with De Novo Unprotected Distal Left Main Bifurcation Coronary Lesions: The MIlan and New-TOkyo (MITO) Registry Catheter Cardiovasc Interv Sep 2 by K.Takagi, S.Nakamura A.Colombo et.al Distal LAD-ISR Both LAD and LCX-TLR LCx ostial ISR alone 30% LAD-TLR 9.2% at 2-years 60% LCX-TLR
18 Kaplan Meier 8-year patients survival n=753 No restenosis N=318 Cumulative Event Rate No Angio F/U N=318 No angiographic FU N=64 LCX-ISR alone N=64 LAD+LCX ISR N=30 LAD-ISR alone N=23 Log rank P<0.001 Days Since PCI
19 Lesson 1 Among restenosis after LMT PCI, restenosis at LCX ostium is not directly link to fatal prognosis in most of the cases. Therefore our focus should be shift to restenosis at LM toward LAD, which strongly affect on patientsʼ fatal prognosis. Letʼs think about RCA???
20 Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo (MITO) registry. Circ Cardiovasc Interv April;6(2); by K.Takagi, S.Nakamura A.Colombo et.al 523 Pts LMT-PCI No CTO RCA 46 Pts LMT-PCI Residual RCA CTO
21 Cumulative event rate at 5 years follow-up by Kaplan-Meier Method: No RCA CTO and RCA CTO (A) Cardiac-death (B) Cardiac-death + MI (C) MACE Log Rank P=0.001 Log Rank P<0.001 Log Rank P=0.861 Log Rank P=0.001 Log Rank P<0.001 Log Rank P= % at 5-years Residual RCA-CTO 20.8% at 5-years 22.7% at 5-years 28.4% at 5-years NO 6.2% RCA-CTO at 5-years 8.1% at 5-years No at Risk (1) (2) 1-year years years No at Risk (1) (2) 1-year years years No at Risk (1) (2) 1-year years years (1) ULM without residual CTO-RCA (ULM with no CTO-RCA + ULM with treated CTO-RCA ) n=522 (2) ULM with residual CTO-RCA n=46
22 Lesson 2 Following PCI of LMT, cardiac-death occurred more frequently in patients with residual CTO-RCA, v while a few cardiac death occurred in patients without residual CTO-RCA. These findings may suggest that recanalization of CTO-RCA may impact v on the long-term cardiac mortality in patients with LMT-PCI.
23 Long-term Clinical Outcome of Single-stent Crossover Technique from Unprotected Left Main Coronary Artery to the Left Circumflex Coronary Artery Naganuma T, Chieffo Alaide, Nakamura S, Colombo A, et al. Catheter Cardiovasc Interv Comparison of LCX ost and LAD ost after Stenting LMCA * LAD LMCA * LAD LCx LCx Ø Restenosis at the LCx-ostium in LMT-LCx stenting group Ø Restenosis at the LAD-ostium in LMT-LAD stenting group
24 Cumulative event rate of TLR at 3 years follow-up by Kaplan-Meier Method Log-rank p <0.001 LMCA-LCx LMCA-LAD TLR(%) 20 Restenosis at LCx-ostium 18.2% 10 Restenosis at LAD-ostium 3.0% No. at risk LMCA-LCx LMCA-LAD Follow-up (years)
25 Lesson 3 LCX ostium itself independently shows high restenosis rate in patients with LMT-PCI. Now we donʼt have consensus for treating LCX ost. Prox. How about BRS???
26 Previous DES 3.0 NC Balloon pre Dilatation BVS 3.5 x 12mm 3.5mm NC balloon
27 Final Angiogram
28 Only 6month later Severe Restenosis in LCX ost.
29 A LAD previously implanted DES 3.5x12mm BVSLCx C D E F GH I C D E F G H I B LAD Small SB LCx J LAD F F overlapping struts LAD Small SB J no struts LM LM LCx LCx C D E F G H I C D E F G H I C D E neo-carina C D E neo-carina overlapping struts LAD G H I SD: 3.03/3.14mm SA: 7.45mm 2 LAD G H I SD: 2.26/2.71mm SA: 5.01mm 2 Small SB overlapping struts Small SB
30 BVS may not be an optimistic solution for an ostial LCX lesion F F overlapping struts no struts
31 Do not chase to much!! LCX is a different animal This is very unique part of coronary artery!!! So called, HINGE POINT... But point is moving and Twitching And not so much important as compared with LAD and RCA for keeping Ejection fraction of the patientʼs HEART
32 About Endothelial activation?? - Letʼs Think about Jailed Strut in LCX Ost.- Letʼs think about 2 stent technique? Is it related with restenotic event?? Yusuke Fujino M.D.
33 3D OCT Image After SES Implantation with inappropriate KBT LCX Malapposed stent struts LMCA Malapposed stent struts LMCA LCX LAD Y Fujino, Marco. A Costa, S Nakamura et al. AHA 2013 scientific session
34 OCT Assessment of LCX ostium at F/U Post PCI malapposed stent struts 9M follow-up A B C Neointimal proliferation over the malapposed stent struts A B C Y Fujino, Marco. A Costa, S Nakamura et al. AHA 2013 scientific session
35 Area Narrowing of LCX ostium by 3D-OCT Post PCI Follow-up 8.85mm mm 2 We calculated area narrowing(%) with this formula Area (post) Area (follow-up) Area Narrowing (%) = 100 Area (post) Y Fujino, Marco. A Costa, S Nakamura et al. AHA 2013 scientific session
36 Area Shrinkage of LCX Ostium Sirolimus-Eluting Stent Cypher: Johnson and Johnson Everolimus-Eluting Stent Xience V: abott vascular SES (n=10) EES (n=15) p Value Post-PCI LCX ostium area, mm ± ± M follow-up LCX ostium area, mm ± ± Area Shrinkage (%) 32.4± ± Y Fujino, Marco. A Costa, S Nakamura et al. AHA 2013 scientific session
37 Case: LMT ost.~body stenosis: EES single crossover stenting without KBT LMT Ost~Body Lesion Single Stenting with Xiemce POT, Full Cover W/O KBT
38 EES single crossover stenting without KBT Post F/U E C A E C A B D D B A Post B C D E FFR; 0.78 Neointimal proliferation over the malapposed stent struts A B C D E F/U
39 Lesson 5 How many jailed struts, or how much area that jailed struts occupies in the area of ostium of LCX seems to be a determinant factor of Future Endotherialization for the coverage of these jailed struts. Finishing the case with optimum KBT is very indispensable for LMT bifurcation PCI
40 Optical coherence tomography assessment of in-stent restenosis after percutaneous coronary intervention with two-stent technique in unprotected left main. Fujino Y, Nakamura S, et al Int J Cardiol May 20;219: After 2 Stent Implantation We can see NIH at CARINA area I 90 FD FD FD FD LW LW LW LW A B C D II LAD A B C D FD LMC A LW LCX
41 OCT Findings of ISR after Two-Stent Technique Fujino Y, Nakamura S, et al Int J Cardiol May 20;219: Protruded NIH of LCX ostium at flow divider side uncovered stent strut LAD C Flow Divider D Flow Divider LMCA Flow Divider A B C D Lateral Wall LCX Lateral Wall Lateral Wall
42 Pre Stent Implantation (physiological) After Stent Implantation (non-physiological) Low Shear Stress Plaque accumulation LW (lateral wall) Implanted Stent Struts accumulation Low Shear Stress Plaque accumulation LW (lateral wall) High Shear Stress FD (flow divider) Neointimal Hyperplasia Neointimal Hyperplasia Uncovered Stent Struts Malapposed Stent Struts
43 Experimental model to study flow pattern Without stent placement Blood flow at carina is quite fast. After stent implantation Flow is delayed, causing turbulence. Without Stent High shear stress (high coronary flow) Culotte Stent Low shear stress (Low coronary flow) This is so-called low shear stress status. It is speculated that stent struts remaining at orifice of circumflex negatively affect the flow.
44 Without stent T- stent Accumulated stent struts might impact the flow pattern then progress the NIH in 2 stent PCI case Crush stent Culottes stent
45 OCT LAD LCX LMCA LCX Unfavorable culotte LAD LMCA Favorable culotte Home Data
46 Favorable culotte Unfavorable culotte LMCA LMCA LAD LAD LCX LCX LMCA LAD LMCA LAD LCX LCX Home Data
47 OCT TAP stenting
48 Follow-up CAG after PCI ISR of LAD proximal ISR of LCX proximal
49 Experimental model to study flow pattern Without stent placement Blood flow at carina is quite fast. Unfavorable TAP stent Flow is roiling, causing turbulence. High shear stress (high coronary flow) Flow Disturbance Home Data
50 Lesson 6 1. As far as bifurcation lesion is untreated, its flow around carina is fast and plaque is not accumulated. 2. However once two stents are placed, flow is delayed and causing turbulence, which is so called low shear stress area, susceptible to plaque deposition. 3. Depending on which double stenting technique is used, flow of CX would be different, and... even whether favorable stenting is achieved or not makes flow pattern different.
51 Happy End... Not Always!!
The 3 top Messages from technique Specific problems Solving
The 3 top Messages from technique Specific problems Solving Alaide Chieffo Interventional Cardiology Unit San Raffaele Hospital Milan - Italy PROBLEMS DURING PROVISIONAL: SB PROTECTION AND RESCUE Francesco
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationPercutaneous Intervention of Unprotected Left Main Disease
Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected
More informationPCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France
PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease
More informationANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention
ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC Seoul, Korea: 25-27 27 April 2007 Session: Left mains & bifurcation intervention An integrated approach to bifurcation lesions: lessons from years of randomized
More informationUnprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy
Unprotected Left Main Stenting: Patient Selection and Recent Experience Alaide Chieffo S. Raffaele Hospital, Milan, Italy Class IIa (Level B) AHA/ACC 2005 Guidelines Left Main CAD The use of PCI for pts
More informationBifurcation Stenting: IVUS and OCT Information
Bifurcation Stenting: IVUS and OCT Information Yoshinobu Murasato MD, PhD (New Yukuhashi Hospital) On behalf of J-REVERSE investigators October 14-15, 2011, Lisbon Proximal stent deformation induced by
More informationImportant LM bifurcation studies update
8 th European Bifurcation Club 12-13 October 2012 - Barcelona Important LM bifurcation studies update I Sheiban E-mail: isheiban@yahoo.com Unprotected LM Percutaneous Revascularization What is important
More informationTechnical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD
Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Onassis Cardiac Surgery Center, Athens, Greece Critical issues in LM PCI Anatomic variability Techniques Variability
More informationSunao Nakamura M.D,Ph.D.
Drug Eluting Stent Implantation For Unprotected Left ain Coronary Arteries New Tokyo Circulation Research Group New Tokyo Hospital Sunao Nakamura.D,Ph.D. Drug-Eluting Stent for Left ain Coronary Artery
More informationΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ
ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ DR ΝΙΚΟΛΑΟΣ ΚΑΥΚΑΣ MD, FESC Διευθυντής, Υπεύθυνος Αιμοδ/κού Εργαστηρίου Καρδιολογική Κλινική Γεν. Νοσοκομείο ΚΑΤ-ΕΚΑ PCI in Coronary Bifurcations Bifurcations
More informationin an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore
Unrelenting Left Main Disease in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore Clinical History 72 years old Chinese lady Background and CV Risk
More informationBifurcation stenting with BVS
Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have
More informationISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions
Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main
More informationIntegrated Use of IVUS and FFR for LM Stenting
Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher
More informationLeft Main and Bifurcation Summit I. Lessons from European LM Studies
Left Main and Bifurcation Summit I Apr 29 8.56-9.09 Lessons from European LM Studies Alaide Chieffo, MD S. Raffaele Hospital, Milan, Italy Nothing to disclose regarding this presentation Lesion Location
More informationFinal Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)
The Microport FIREBIRD Polymer-based Sirolimus- Eluting Stent Clinical Trial Program Update: The FIC and FIREMAN Registries Junbo Ge, MD, FACC, FESC, FSCAI On behalf of Runlin Gao (FIC PI) and Haichang
More informationFFR-guided Jailed Side Branch Intervention
FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still
More informationProtection of side branch is essential in treating bifurcation lesions: overview
Angioplasty Summit TCT Asia Pacific Seoul, April 26-28, 2006 Protection of side branch is essential in treating bifurcation lesions: overview Alfredo R Galassi, MD, FACC, FSCAI, FESC Head of the Catetherization
More informationDrug Eluting Stents: Bifurcation and Left Main Approach
TCT Asia 2006 Drug Eluting Stents: Bifurcation and Left Main Approach Eberhard Grube MD FACC, FSCAI Heart Center,, Germany Stanford University, School of Medicine, CA, USA DES in High Risk Lesions TAXUS
More informationManagement of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI
Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent Masahiko Ochiai MD, FACC, FESC, FSCAI Division of Cardiology and Cardiovascular Surgery Showa University Northern Yokohama Hospital
More informationSide Branch Occlusion
Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion
More informationNon-LM bifurcation studies of importance in 2011
7th European Bifurcation Club 14-15 October 2011 LISBON Goran Stankovic MD, PhD Non-LM bifurcation studies of importance in 2011 October 15 th : 08:00 08:10 DKCRUSH-II: A Prospective Randomized Trial of
More informationPROMUS Element Experience In AMC
Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical
More informationPCI for Left Anterior Descending Artery Ostial Stenosis
PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary
More informationLeft Main Intervention: Will it become standard of care?
Left Main Intervention: Will it become standard of care? David Cox, MD FSCAI, FACC Director, Interventional Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown,
More informationSeptember Peter Barlis. Royal Brompton Hospital, London, UK
3rd EBC Meeting European Bifurcation Club September 2007 PALAU DE LA MUSICA, SalaRodrigo VALENCIA, SPAIN Culotte Technique in Left Main Disease Peter Barlis Carlo DiMario Royal Brompton Hospital, London,
More informationIncidence and Treatment for LM In-Stent
Incidence and Treatment for LM In-Stent Restenosis Corrado Tamburino, MD, PhD Full Professor of Cardiology, Director of Postgraduate School of Cardiology Chief Cardiovascular Department, Director Cardiology
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationIVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.
Left Main and Bifurcation Summit IVUS-Guided d Provisional i Stenting: ti Plaque or Carina Shift Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan College of Medicine Asan Medical Center,
More informationPCI for LMCA lesions A Review of latest guidelines and relevant evidence
HCS Working Group Seminars Met Hotel, Thursday 14 th February 2013 PCI for LMCA lesions A Review of latest guidelines and relevant evidence Vassilis Spanos Interventional Cardiologist, As. Director 3 rd
More informationBifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece
Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece The not so new development One vs. two stents General consensus In most bifurcational
More informationResolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Prof. Ran Kornowski, MD, FESC, FACC Director - Division of Interventional Cardiology Rabin Medical Center and Tel Aviv University,
More informationLeft Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD
Left Main PCI Integrated Use of IVUS and FFR Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea Efficacy of Left
More informationCoronary interventions
Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF
More informationLe# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy
Le# main treatment with Stentys stent Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement
More informationEXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017
EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 Igor F. Palacios, MD Director of Interventional Cardiology Professor of Medicine Massachusetts
More informationLeft main coronary artery (LMCA): The proximal segment
Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary
More informationRationale for Percutaneous Revascularization ESC 2011
Rationale for Percutaneous Revascularization Marie Claude Morice, Massy FR MD, FESC, FACC ESC 2011 Paris Villepinte - 27-31 August, 2011 Massy, France Potential conflicts of interest I have the following
More informationComplex Coronary Interventions: Bifurcations. John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri
Complex Coronary Interventions: Bifurcations John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri Disclosures Advisory Board Boston Scientific, St. Jude Medical Speaker-
More informationBench test : Is it still useful? Do we need standardization?
How to evaluate stents and techniques for bifurcation stenting? Bench test : Is it still useful? Do we need standardization? Yoshinobu Murasato MD, PhD Dept. of Cardiovascular Medicine, New Yukuhashi Hospital
More informationKurdistan Technique for the Treatment of Unprotected Trifurcation Left Main Stem Coronary Artery Lesion: Case Report
World Journal of Cardiovascular Diseases, 2014, 4, 483-491 Published Online August 2014 in SciRes. http://www.scirp.org/journal/wjcd http://dx.doi.org/10.4236/wjcd.2014.49058 Kurdistan Technique for the
More informationDEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.
DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. In-stent restenosis (ISR) Remains important issue even in the
More informationI have nothing to disclose.
I have nothing to disclose. ESC congress of cardiology, 25-29th August 2012, Munich, Germany Minsk-Village 6, August 26 th, 2:22 PM Session: The grey zone of coronary interventions: The real bifurcation
More informationKomplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents
Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors
More informationDr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot'
OCT guided BVS for LMCA to LAD : Optimising the 'Pot' Dr Aniket Puri MD,DM,FRACP, FACC, FSCAI, FAPSIC Consultant Interventional Cardiologist Christchurch Hospital and Canterbury DHB(Univ of Otago) Christchurch,New
More informationSTENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy
STENTYS for Le, Main Sten2ng Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement or affilia2on
More informationPCI for Bifurcation Coronary Lesion
PCI for Bifurcation Coronary Lesion Bifurcation Lesions PCI is Challenging Higher acute complication Lower success rates Higher restenosis & TLR Restenosis Rate 21 ~ 57% TLR 8 ~ 43% Event Free Survival
More informationRun-Lin Gao, MD, FACC. On Behalf of I-LOVE-IT Trial Investigators
I-LOVE-IT A Prospective, Multicenter Clinical Trial of TIVOLI Bioabsorbable Polymer Based Sirolimus-Eluting vs. ENDEAVOR Zotarolimus- Eluting Stent in Patients with Coronary Artery Disease: 8-Month Angiographic
More informationΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική
ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική X. ΓΡΑΪΔΗΣ Επεμβατικός καρδιολόγος, FSCAI Kλινική Euromedica-Κυανούς Σταυρός, Θεσσαλονίκη The Fear factor The two words LEFT MAIN
More informationPerspective of LM stenting with Current registry and Randomized Clinical Data
Asian Pacific TCT Perspective of LM stenting with Current registry and Randomized Clinical Data Patrick W. Serruys MD PhD Yoshinobu Onuma MD Seung-Jung Park MD, PhD 14:48-15:00, 2009 Symposium Arena, Level
More informationAntonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017
Parigi: May 16-19, 2017 Miracor Symposium Speaker: 15 Antonio Colombo Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy Nothing to disclose PiCSO Impulse System Elective high risk
More informationPost PCI functional testing and imaging: case based lessons from FFR React
Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest
More informationDISCOVER Ultimaster with Optical Frequency Domain Imaging
DISCOVER Ultimaster with Optical Frequency Domain Imaging David Hildick-Smith Sussex Cardiac Centre Brighton and Sussex University Hospitals United Kingdom Potential conflicts of interest Speaker's name:
More informationCatch-up Phenomenon: Insights from Pathology
Catch-up Phenomenon: Insights from Pathology Michael Joner, MD CVPath Institute Inc. Gaithersburg, MD USA Path Lessons learned from the BMS and DES (1 st Gen) era Neointimal Thickness [mm] In Stent Re
More informationPCI for Long Coronary Lesion
PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2
More informationLessons for technique and stent choice
8 th European Bifurcation Club 12-13 October 2012 - Barcelona Session: What are the requirements for using a stent in a bifurcation? Lessons for technique and stent choice October 12 th : 16:45 17:50 Goran
More informationLong-term outcomes of simple crossover stenting from the left main to the left anterior descending coronary artery
ORIGINAL ARTICLE Korean J Intern Med 2014;29:597-602 Long-term outcomes of simple crossover stenting from the left main to the left anterior descending coronary artery Ho-Myung Lee 1,*, Chang-Wook Nam
More informationDK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi
PCI for Bifurcations: Which is the best strategy DK Crush,Culotte,SKS,T or TAP Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi CSI 2018 Selection
More informationComplex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ".
Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ". "Σύμπλοκη αγγειοπλαστική βλάβης διχασμού LAD/Diagonal (Medina 1,1,1) με την τεχνική DK crush ". Anastasios
More informationLeft Main Intervention: Where are we in 2015?
Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa
More informationAssessing Myocardium at Risk: Applying SYNTAX
Assessing Myocardium at Risk: Applying SYNTAX Farouc Jaffer MD PhD FSCAI FACC FAHA Associate Professor of Medicine, Harvard Medical School Director, CAD Program and Chronic Total Occlusion PCI Program
More informationHCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February Drug-eluting stents Are they all equal?
HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February 2014 Drug-eluting stents Are they all equal? Vassilis Spanos Interventional Cardiologist, As. Director 3 rd Cardiology Clinic Euroclinic
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationOCT guidance for distal LM lesions
OCT guidance for distal LM lesions FRANCESCO BURZOTTA INSTITUTE OF CARDIOLOGY CATHOLIC UNIVERSITY OF THE SACRED HEART ROME, ITALY LM suitability for OCT At FU in stented LM Parodi G et al. Eurointervention
More informationFFR and intravascular imaging, which of which?
FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment
More informationStent Fracture and Longitudinal Compression on CT Angiography between the
2014 ASCI Stent Fracture and Longitudinal Compression on CT Angiography between the First- and New-Generation Drug-Eluting Stent Mi Sun Chung, Dong Hyun Yang,Young-Hak Kim, Jae-Hyung Roh, Joon-Won Kang,
More informationAnalysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent
Analysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent implantation. Department of Cardiology, Ehime Prefectural Imabari
More informationMedtronic Symposium The Complex Bifurcation Patient: new insights into stent selection
Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection Carlo Trani, MD, FESC Cardiology Department, Catholic University of the Sacred Heart, Rome - Italy How would you treat
More informationEBC Rules of Bifurcation PCI
EBC Rules of Bifurcation PCI Y. Louvard, ICPS, Massy, France What is a coronary bifurcation? «Murray s law» Bifurcation branching laws D1 Murray s law D 3* 3* 3* 1 = D 2 + D 3 D3 Finet s law D 1 = 0.67(D
More informationCount Down to COMBAT
Count Down to COMBAT Randomized COMparison of Bypass Surgery versus AngioplasTy using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease Roxana Mehran, MD Associate Professor of
More informationPlaque Shift vs. Carina Shift Prevalence and Implication
TCTAP 2013 Fellowship Course Left Main and Bifurcation PCI: Bifurcation PCI Plaque Shift vs. Carina Shift Prevalence and Implication Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan
More informationMULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION
MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica Kyanous Stavros, Thessaloniki.
More informationConsensus so far and what we will be focusiong on this time
Consensus so far and what we will be focusiong on this time The 6 th European Bifurcation Club Meeting Budapest October 22-23 2010 Jens Flensted Lassen, MD, PH.D., FESC. Department of Cardiology B Skejby
More informationPCI for In-Stent Restenosis. CardioVascular Research Foundation
PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse
More informationLong inflation to left main coronary artery with kissing balloon inflation by drug-coated balloon and perfusion balloon
com Nakabayashi et al. 1 Original case report Article Peer Reviewed OPEN ACCESS Long inflation to left main coronary artery with kissing balloon inflation by drug-coated balloon and perfusion balloon Keisuke
More information6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France
6 th European Bifurcation Club 22-23 October 2010 - BUDAPEST Kissing in simple strategy? Why and how I kiss Y. Louvard, ICPS, Massy France A long experience of kissing 1996 Patients 79 Final Kissing balloon
More informationIVUS vs FFR Debate: IVUS-Guided PCI
IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement
More informationPCI for Chronic Total Occlusions
PCI for Chronic Total Occlusions Chronic Total Occlusions Why not Medical Treatment? Medical Treatment CTO in 891 pts over 24 years High 10% Mortality Low 2 % 1 year 10 years Puma JA, et al. JACC 1994;23:390A
More informationAre Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &
Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) & Biomatrix TM Single Center Experience (Indonesia)(Final 5 Yr F up) T. Santoso University of
More informationINTERVENTIONAL VASCULAR DIAGNOSTICS AND THERAPY. SeQuent Please NEO CLINICAL EVIDENCE AND COST / BENEFIT EFFECTIVENESS
INTERVENTIONAL VASCULAR DIAGNOSTICS AND THERAPY SeQuent Please NEO CLINICAL EVIDENCE AND COST / BENEFIT EFFECTIVENESS Table of Contents Overview SeQuent Please - DCB Scientific Publications SeQuent Please
More informationFor Personal Use. Copyright HMP 2013
Case Report J INVASIVE CARDIOL 2013;25(2):E39-E41 A Case With Successful Retrograde Stent Delivery via AC Branch for Tortuous Right Coronary Artery Yoshiki Uehara, MD, PhD, Mitsuyuki Shimizu, MD, PhD,
More informationBIOFREEDOM: Polymer free Biolimus A9 eluting
TCTAP 2011 Seoul, April 27 29, 2011 BIOFREEDOM: Polymer free Biolimus A9 eluting Stents and Paclitaxel eluting stents Eberhard Grube MD, FACC, FSCAI Hospital Oswaldo Cruz - Dante Pazzanese, São Paulo,
More informationhigh SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy
What to do with patients with high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin San Giovanni Battista Hospital Turin / Italy Who are the patients with high SYNTAX
More informationPerioperative Management After Coronary Stenting: Risk Assessment Before Surgery. Christian Seiler No conflict of interest to declare.
Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery Christian Seiler No conflict of interest to declare PCI Long-Term Outcome Perioperative Management After Coronary Stenting:
More informationStent Thrombosis in Bifurcation Stenting
Summit TCT Asia Pacific 2009 Stent Thrombosis in Bifurcation Stenting Associate Professor Tan Huay Cheem MBBS, M Med(Int Med), MRCP, FRCP(UK), FAMS, FACC, FSCAI Director, National University Heart Centre,
More informationIntracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington.
Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington. Medstar Washington Hospital Center Washington, DC Conflict of Interest None for this
More informationBasics of Angiographic Interpretation Analysis of Angiography
Basics of Angiographic Interpretation Analysis of Angiography Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Seoul, Korea What made us nervous Supervisors Stent Contrast
More informationCURRICULUM VITAE PRESENTATION AT THE CONFERENCE
CURRICULUM VITAE PRESENTATION AT THE CONFERENCE 1. Sato K, Takebayashi H, et al. Tissue characterization by use of integrated backscatter intravascular ultrasound may predict late lumen loss after drug
More informationΑγγειοπλαστική σε Eπαναστενωτικές Bλάβες
Αγγειοπλαστική σε Eπαναστενωτικές Bλάβες Βάιος Π. Τζίφος Δ/ντής Γ Καρδιολογικής Κλινικής - Επεμβατικής Καρδιολογίας. Ερρίκος Ντυνάν HC The Mehran s Classification for BMS-ISR Prognostic Value Pattern (1)
More informationDES In-stent Restenosis
DES In-stent Restenosis Roxana Mehran, MD Columbia University Medical Center The Cardiovascular Research Foundation DES Restenosis Mechanisms Predictors Morphological patterns Therapy approach Mechanisms
More informationDrug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo
Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis 11.45-12.07 Alaide Chieffo San Raffaele Scientific Institute, Milan, Italy Historical Perspective 25 20 15 10 5 0 Serruys 1991
More informationTCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI
Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi
More informationDRUG-COATED BALLOONS AND CORONARY BIFURCATION LESIONS
DRUG-COATED BALLOONS AND CORONARY BIFURCATION LESIONS *Alessandro Durante, 1 Pietro Leonida Laforgia 2 1. Ospedale Valduce, Como, Italy 2. Università degli Studi di Milano, Milan, Italy *Correspondence
More informationSirolimus Nanocrystal Balloon Based Delivery for Coronary DES ISR
Sirolimus Nanocrystal Balloon Based Delivery for Coronary DES ISR DR. SAMEER I DANI Director, Department of Cardiology, Apollo Hospital & Life Care Institute (LIMSAR), Ahmedabad, India. IN STENT RESTENOSIS
More informationThe Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD
The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections Martin B. Leon, MD Columbia University Medical Center Cardiovascular Research Foundation New York City Angioplasty
More informationOCTOBER. OCT Optimised Bifurcation Event Reduction. A Nordic Baltic British clinical outcome trial
OCT Optimised Bifurcation Event Reduction A Nordic Baltic British clinical outcome trial NIELS RAMSING HOLM, Skejby Denmark Study start: OCTOBER 2016 OCTOBER LMCA or non-lmca bifurcations with SB 2.5mm
More informationThe SYNTAX-LE MANS Study
The SYNTAX-LE MANS Study Synergy Between PCI with TAXUS Express and Cardiac Surgery: Late (15-month) Left Main Angiographic Substudy A. Pieter Kappetein, MD, PhD Erasmus MC, Rotterdam, NL SYNTAX-LE MANS
More informationBioresorbable polymer drug-eluting stents in PCI
EARN 3 FREE CPD POINTS CARDIOVASCULAR Leader in digital CPD for Southern African healthcare professionals The BIOFLOW-V trial, using the Orsiro ultrathin strut stent with biodegradable polymer, showed
More information